tiprankstipranks
Trending News
More News >
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
US Market
Advertisement

Neuphoria Therapeutics (NEUP) Income Statement

Compare
302 Followers

Neuphoria Therapeutics Income Statement

Last quarter (Q1 2026), Neuphoria Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q1, Neuphoria Therapeutics's net income was $-14.99M. See Neuphoria Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 23.95M$ 0.00$ 0.00-$ 0.00
Gross Profit
$ 22.94M$ -992.56K$ -671.42K$ 0.00$ -1.69M
Operating Expenses
$ 24.67M$ 25.79M$ 21.58M$ 27.71M$ 11.26M
Depreciation and Amortization
$ 1.01M$ 992.56K$ 671.42K$ 1.17M$ 1.69M
EBITDA
$ -268.02K$ -22.33M$ -21.54M$ -28.03M$ -6.63M
Operating Income
$ -1.73M$ -26.79M$ -22.26M$ -28.60M$ -12.95M
Other Income/Expenses
$ 445.56K$ 3.46M$ 39.87K--
Pretax Income
$ -1.28M$ -23.32M$ -22.22M$ -29.24M$ -9.76M
Net Income
$ -565.77K$ -23.19M$ -21.65M$ -22.94M$ -8.65M
Per Share Metrics
Basic EPS
$ -0.23$ -0.10$ -0.17$ -0.13$ -0.10
Diluted EPS
$ -0.23$ -0.10$ -0.17$ -0.13$ -0.10
Weighted Average Shares Outstanding
1.62M 149.80M 122.39M 112.78M 65.00M
Weighted Average Shares Outstanding (Diluted)
1.62M 149.80M 122.39M 112.78M 65.00M
Currency in USD

Neuphoria Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis